Delivery Order V797D30042-36C26021F0117
Award Date 12/1/20
Potential Completion Date 9/30/21
Potential Value $75K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a firm fixed price delivery order contract for PROLASTIN C, a pharmaceutical product, to Grifols Therapeutics LLC, a for-profit limited liability company and manufacturer. The contract was awarded on October 1, 2021 with a potential value of $454,461.44 and a completion date of September 30, 2022. The contract was issued under the Pharmaceuticals and Drugs GSA Schedule, which is a government-wide acquisition...
- This is a federal contract award for PROLASTIN to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $219,999.96, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 and did not utilize any small business set-asides. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply...
- This federal contract award is for PROLASTIN-C, a pharmaceutical product, awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $355,273.02 firm fixed price delivery order is under the Pharmaceuticals and Drugs GSA Schedule contract vehicle and does not utilize any small business set-asides. Grifols Therapeutics has previously been awarded other federal...
- This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $223,184.16, is for the provision of PROLASTIN C, a pharmaceutical product, to the VA under the Pharmaceuticals and Drugs GSA Schedule contract. The contract is a firm fixed-price delivery order with a period of performance ending on September 30, 2017. The contract was...
- This is a $319,369.68 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which is not set aside, is for the delivery of the pharmaceutical product PROLASTIN C. It is a firm fixed price contract with a period of performance ending on September 30, 2020. Grifols Therapeutics LLC is a long-standing federal contractor, having...
- This contract award is for the pharmaceutical product PROLASTIN, provided by Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which does not utilize any set-asides, was awarded on October 19, 2018 by the Department of Veterans Affairs Veterans Health Administration for a total potential value of $100,131.84. The contract is a Blanket Purchase Agreement (BPA) call, with a firm-fixed price, and is associated with the Pharmaceuticals and...
- This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...
- This federal contract award was issued by the Veterans Integrated Service Network 7 (VISN 7), a regional network within the Department of Veterans Affairs. The contract, valued at $82,333.44, is a Blanket Purchase Agreement (BPA) call order for the pharmaceutical product Prolastin-C. The prime contractor is Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract was not set aside for any small business designation. This award is...
- This federal contract award is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, to the Department of Veterans Affairs (VA). The contract was awarded to Grifols USA LLC, a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. The contract is a Delivery Order with a Firm Fixed Price of $120,000.00 and an ultimate...
- This is a Firm Fixed Price delivery order under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), awarded by the Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC. The award is for the bulk supply of Prolastin, a pharmaceutical drug, for the period from February 1, 2016 to January 31, 2017, with a potential ceiling value of $320,438.40. The award does not utilize any set-aside designation. Grifols Therapeutics LLC is a...